Sickle cell disease: A multigenic perspective of a single-gene disorder

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Although significant progress has been made in our understanding of sickle cell disease (SCD) and in the development of new therapies, many questions are still unanswered, and a cure remains elusive. This is particularly evident in the clinical heterogeneity of the disease. Studies have shown the importance of high hemoglobin F determinants and α-thalassemia as modifiers of disease severity, but these alone do not explain the diversity that is seen. This paper focuses on recent advances on the effect of nonglobin genetic modifiers on the SCD phenotype. The roles of polymorphic variants of (1) methylene- tetrahydrofolate reductase gene in the pathogenesis of avascular necrosis, (2) factor V R485Kand risk of venous thrombosis, and (3) UDP glucuronosyltransferase-1 polymorphism on serum bilirubin levels in SCD are discussed. Mention is made of genetic polymorphisms that might predispose to stroke. The application of gene expression profiling to the study of SCD is very promising and some preliminary data are provided.

Original languageEnglish (US)
Pages (from-to)15-19
Number of pages5
JournalMedical Principles and Practice
Volume14
Issue numberSUPPL. 1
DOIs
StatePublished - Aug 26 2005

Fingerprint

Sickle Cell Anemia
Genes
Methylenetetrahydrofolate Reductase (NADPH2)
Fetal Hemoglobin
Glucuronosyltransferase
Thalassemia
Factor V
Gene Expression Profiling
Genetic Polymorphisms
Bilirubin
Venous Thrombosis
Necrosis
Stroke
Phenotype
Serum
Therapeutics

Keywords

  • Genetic polymorphisms
  • Sickle cell disease

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Sickle cell disease : A multigenic perspective of a single-gene disorder. / Kutlar, Abdullah.

In: Medical Principles and Practice, Vol. 14, No. SUPPL. 1, 26.08.2005, p. 15-19.

Research output: Contribution to journalArticle

@article{deeb03f3057e416eae088520861ee71d,
title = "Sickle cell disease: A multigenic perspective of a single-gene disorder",
abstract = "Although significant progress has been made in our understanding of sickle cell disease (SCD) and in the development of new therapies, many questions are still unanswered, and a cure remains elusive. This is particularly evident in the clinical heterogeneity of the disease. Studies have shown the importance of high hemoglobin F determinants and α-thalassemia as modifiers of disease severity, but these alone do not explain the diversity that is seen. This paper focuses on recent advances on the effect of nonglobin genetic modifiers on the SCD phenotype. The roles of polymorphic variants of (1) methylene- tetrahydrofolate reductase gene in the pathogenesis of avascular necrosis, (2) factor V R485Kand risk of venous thrombosis, and (3) UDP glucuronosyltransferase-1 polymorphism on serum bilirubin levels in SCD are discussed. Mention is made of genetic polymorphisms that might predispose to stroke. The application of gene expression profiling to the study of SCD is very promising and some preliminary data are provided.",
keywords = "Genetic polymorphisms, Sickle cell disease",
author = "Abdullah Kutlar",
year = "2005",
month = "8",
day = "26",
doi = "10.1159/000086180",
language = "English (US)",
volume = "14",
pages = "15--19",
journal = "Medical Principles and Practice",
issn = "1011-7571",
publisher = "S. Karger AG",
number = "SUPPL. 1",

}

TY - JOUR

T1 - Sickle cell disease

T2 - A multigenic perspective of a single-gene disorder

AU - Kutlar, Abdullah

PY - 2005/8/26

Y1 - 2005/8/26

N2 - Although significant progress has been made in our understanding of sickle cell disease (SCD) and in the development of new therapies, many questions are still unanswered, and a cure remains elusive. This is particularly evident in the clinical heterogeneity of the disease. Studies have shown the importance of high hemoglobin F determinants and α-thalassemia as modifiers of disease severity, but these alone do not explain the diversity that is seen. This paper focuses on recent advances on the effect of nonglobin genetic modifiers on the SCD phenotype. The roles of polymorphic variants of (1) methylene- tetrahydrofolate reductase gene in the pathogenesis of avascular necrosis, (2) factor V R485Kand risk of venous thrombosis, and (3) UDP glucuronosyltransferase-1 polymorphism on serum bilirubin levels in SCD are discussed. Mention is made of genetic polymorphisms that might predispose to stroke. The application of gene expression profiling to the study of SCD is very promising and some preliminary data are provided.

AB - Although significant progress has been made in our understanding of sickle cell disease (SCD) and in the development of new therapies, many questions are still unanswered, and a cure remains elusive. This is particularly evident in the clinical heterogeneity of the disease. Studies have shown the importance of high hemoglobin F determinants and α-thalassemia as modifiers of disease severity, but these alone do not explain the diversity that is seen. This paper focuses on recent advances on the effect of nonglobin genetic modifiers on the SCD phenotype. The roles of polymorphic variants of (1) methylene- tetrahydrofolate reductase gene in the pathogenesis of avascular necrosis, (2) factor V R485Kand risk of venous thrombosis, and (3) UDP glucuronosyltransferase-1 polymorphism on serum bilirubin levels in SCD are discussed. Mention is made of genetic polymorphisms that might predispose to stroke. The application of gene expression profiling to the study of SCD is very promising and some preliminary data are provided.

KW - Genetic polymorphisms

KW - Sickle cell disease

UR - http://www.scopus.com/inward/record.url?scp=23844549214&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=23844549214&partnerID=8YFLogxK

U2 - 10.1159/000086180

DO - 10.1159/000086180

M3 - Article

C2 - 16103709

AN - SCOPUS:23844549214

VL - 14

SP - 15

EP - 19

JO - Medical Principles and Practice

JF - Medical Principles and Practice

SN - 1011-7571

IS - SUPPL. 1

ER -